Pfizer Inc. and BioNTech SE have announced that they are currently seeking approval for the release of their COVID-19 vaccine booster shot. The application is scheduled to be submitted by the end of this week.
Competitors such as Moderna and Johnson & Johnson are making inroads of their own with regard to vaccine distribution.
Moderna Inc. has confirmed that it has applied for full approval of its COVID-19 vaccine in the United States, while Johnson & Johnson has determined in recent trials that its own booster shot has provided a steep increase in antibodies for recipients.
While vaccine makers have ramped up their own rollout efforts, several major US companies have implemented their own regulations in order to curb the spread of COVID-19.
Atlanta, Georgia-based airline Delta Air Lines Inc. has confirmed that it will begin issuing a $200 monthly surcharge to employees who do not get vaccinated. Credit Suisse Group AG has also introduced new procedures, including the postponement of the date that employees will be able to return to the physical office space.
Deutsche Bank AG has taken the stance to only allow fully vaccinated employees onto its trading floors in the United States.
